The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.

By C. Abbott, M. Monteiro, C. Small, A. Sajedi, Kirsty L. Smith, J. R. Parkinson, M. Ghatei, Stephen R. Bloom. Brain Research, 2005

598 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/6abefcbc4e3bbb2db8ee8cb8f234b2f325cfaa94

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Josephine M. Egan
2. Wook Kim

Citations in the corpus

• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment (2008, background): “Feeding inhibition of GLP-1 is abolished by ablation of vagal-brainstem-hypothalamic pathway through either subdiaphragmatic total truncal vagotomy or surgical transection of brainstem-hypothalamic pathway in rodents (Abbott et al., 2005), and also by capsaicin, which causes selective degeneration o”